Wouter is a partner and member of the founding team at Illumina Ventures. He has more than 15 years of experience in the development and funding of life-science tools and genomics. Prior to joining Illumina Ventures, he served as the director of corporate development at Illumina Inc., where his main focus was venture investing and mergers-and-acquisitions. At Illumina, Wouter led investments that included Desktop Genetics (acquired in 2018 by Celixir) and Biota Technologies (currently an Illumina Ventures portfolio company).
Wouter graduated magna cum laude from the University of Ghent, Belgium, where he obtained BSc and MSc degrees in chemistry; he went on to earn a PhD in chemical engineering from the University of Newcastle in the United Kingdom and an MBA from the University of Cambridge, also in the U.K.